Valappil T - Search Results

1

Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and Drug Administration's Evaluation.

Chan-Tack K, Harrington P, Bensman T, Choi SY, Donaldson E, O'Rear J, McMillan D, Myers L, Seaton M, Ghantous H, Cao Y, Valappil T, Birnkrant D, Struble K. Chan-Tack K, et al. Among authors: valappil t. Antiviral Res. 2021 Nov;195:105182. doi: 10.1016/j.antiviral.2021.105182. Epub 2021 Sep 25. Antiviral Res. 2021. PMID: 34582915 Review.

2

Sustained virological response rates with direct-acting antivirals in black subjects with HCV genotype 1 infection: systematic analysis of clinical trials.

Struble K, Chan-Tack K, Qi K, Valappil T, Connelly S, Mishra P, Price D, Murray J, Birnkrant D. Struble K, et al. Among authors: valappil t. J Virus Erad. 2019 Sep 18;5(3):138-144. doi: 10.1016/S2055-6640(20)30043-1. J Virus Erad. 2019. PMID: 31700657 Free PMC article.

3

Hierarchical nested trial design (HNTD) for demonstrating treatment efficacy of new antibacterial drugs in patient populations with emerging bacterial resistance.

Huque MF, Valappil T, Soon GG. Huque MF, et al. Among authors: valappil t. Stat Med. 2014 Nov 10;33(25):4321-36. doi: 10.1002/sim.6233. Epub 2014 Jun 23. Stat Med. 2014. PMID: 24957660

4

Methods for efficacy evaluations of antibacterial treatments in multiple body-site infection trials.

Huque MF, Valappil T, Alosh M, Soon G. Huque MF, et al. Among authors: valappil t. J Biopharm Stat. 2019;29(6):1153-1169. doi: 10.1080/10543406.2016.1239897. Epub 2016 Nov 1. J Biopharm Stat. 2019. PMID: 27669364

5

Historical and regulatory perspectives on the treatment effect of antibacterial drugs for community-acquired pneumonia.

Singer M, Nambiar S, Valappil T, Higgins K, Gitterman S. Singer M, et al. Among authors: valappil t. Clin Infect Dis. 2008 Dec 1;47 Suppl 3:S216-24. doi: 10.1086/591407. Clin Infect Dis. 2008. PMID: 18986293 Review.

6

Overview of recent studies of community-acquired pneumonia.

Higgins K, Singer M, Valappil T, Nambiar S, Lin D, Cox E. Higgins K, et al. Among authors: valappil t. Clin Infect Dis. 2008 Dec 1;47 Suppl 3:S150-6. doi: 10.1086/591397. Clin Infect Dis. 2008. PMID: 18986282 Review.

7

Robust extraction of covariate information to improve estimation efficiency in randomized trials.

Moore KL, Neugebauer R, Valappil T, Laan MJ. Moore KL, et al. Among authors: valappil t. Stat Med. 2011 Aug 30;30(19):2389-408. doi: 10.1002/sim.4301. Epub 2011 Jul 12. Stat Med. 2011. PMID: 21751231 Free PMC article.

8

Meta-analysis of a possible signal of increased mortality associated with cefepime use.

Kim PW, Wu YT, Cooper C, Rochester G, Valappil T, Wang Y, Kornegay C, Nambiar S. Kim PW, et al. Among authors: valappil t. Clin Infect Dis. 2010 Aug 15;51(4):381-9. doi: 10.1086/655131. Clin Infect Dis. 2010. PMID: 20624065

9

Consistency ensured test strategies for supportive evidence of treatment efficacy in noninferiority clinical trials.

Huque M, Valappil T, Alosh M. Huque M, et al. Among authors: valappil t. J Biopharm Stat. 2018;28(1):1-14. doi: 10.1080/10543406.2017.1399899. Epub 2017 Nov 27. J Biopharm Stat. 2018. PMID: 29173026

10

Registration trials of antibacterial drugs for the treatment of nosocomial pneumonia.

Sorbello A, Komo S, Valappil T, Nambiar S. Sorbello A, et al. Among authors: valappil t. Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S36-41. doi: 10.1086/653038. Clin Infect Dis. 2010. PMID: 20597669 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters